BULACAN STATE UNIVERSITY

COLLEGE OF NURSING
City of Malolos, Bulacan

DRUG STUDY

Patient’s Initial: _Mrs. K ______________ Age: _32 y/o____ Gender: _F____ Date Handled: __ July 9, 2002____ ____ Medical Diagnosis: _______________________
Chief Complaint: __ Persistent uterine contractions __ Hospital: ___ BSU Medical Hospital___ __________ Ward/Clinical Area: __________________

MEDICATIONS DATE ROUTE OF MECHANISM OF INDICATION CONTRAINDICATION CLIENT’S NURSING

ORDERED/ ADMINISTRATION/ ACTION RESPONSE RESPONSIBILITIES

GIVEN/ DOSAGE/
FREQUENCY
TAKEN

Generic: Date Route: Causes potent and To reduce Contraindicated in Maternal Prior:
ordered: selective postpartum patients hypersensitive
Oxytocin IM stimulation of bleeding after to drug. - Explain use
July 09, 2002 uterine and expulsion of and
CNS: administration
mammary gland placenta.
Date taken: subarachnoid of drug to
Brand: Dosage: smooth muscle. Contraindicated when hemorrhage, patient and
July 09, 2002 vaginal delivery isn't seizures, coma.
Pitocin 10 units family.
advised (placenta - Instruct the
previa, vasa previa, patient the
invasive cervical right route,
CV: arrhythmias,
Classification: Frequency: carcinoma, genital HTN, PVCs. dosage, and
herpes), when frequency of
Therapeutic class: PRN
cephalopelvic the drug.
Oxytocics
disproportion is - Monitor Vital
present, or when GI: nausea,
Signs
delivery requires vomiting.
Pharmacologic class: conversion, as in - Advise patient
BulSU-OP-CON-23F1
Revision: 0
 Exogenous transverse lie. to report any
hormones adverse
GU: abruptio reactions.
placentae, tetanic (site irritation,
Contraindicated in fetal uterine. nausea,
distress when delivery contractions, bleeding,
isn't imminent, in postpartum blurred vision,
prematurity, in other hemorrhage, uter difficulty
obstetric emergencies, ine rupture, speaking,
and in patients with impaired uterine wheezing,
severe toxemia or blood flow, pelvic itching,
hypertonic uterine hematoma, swelling).
patterns. increased uterine
motility.

During:

Hematologic: - Check Vital

afibrinogenemia, Signs
possibly related to - Monitor
postpartum patient for
bleeding. any adverse
reactions.
- Discontinue
oxytocin
Other:
infusion
anaphylaxis,
immediately if
death from
uterine
oxytocin induced
hyperactivity
water intoxication,
occurs.
hypersensitivity
Administer
reactions.
oxygen to the
mother.
- Monitor Fluid

BulSU-OP-CON-23F1
Revision: 0
 intake and
output. Anti-
diuretic effect
may lead to
fluid overload,
seizures, and
coma from
water
intoxication.

After:

- Report any
significant
adverse
reactions (site
irritation,
nausea,
bleeding,
blurred vision,
difficulty
speaking,
wheezing,
itching,
swelling).

- Monitor for
the vital signs
- Monitor and
record uterine
contractions
and character
BulSU-OP-CON-23F1
Revision: 0
 of blood loss
at least every
15 minutes

Student’s Name: ____Ambeguia, Elijah Ronnie C.______ Yr&Sec/Group No. ____BSN 2D_G3____ Clinical Instructor:___ ___Maam. Ana R. Guballa______

BulSU-OP-CON-23F1
Revision: 0